Established and Emerging Biomarkers of Immunotherapy in Renal Cell Carcinoma

The authors discuss biomarkers for immunotherapy in renal cell carcinoma (RCC), highlighting current practices and emerging innovations, aiming to contribute to improved outcomes for patients with RCC.